201 related articles for article (PubMed ID: 34546980)
21. Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis.
Wang H; Zhang N; Wu X; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Dec; 98(12):2629-2639. PubMed ID: 31754743
[TBL] [Abstract][Full Text] [Related]
22. The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
Palangat M; Anastasakis DG; Fei DL; Lindblad KE; Bradley R; Hourigan CS; Hafner M; Larson DR
Genes Dev; 2019 May; 33(9-10):482-497. PubMed ID: 30842218
[TBL] [Abstract][Full Text] [Related]
23. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
[TBL] [Abstract][Full Text] [Related]
24. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
[TBL] [Abstract][Full Text] [Related]
25. Full-length transcript alterations in human bronchial epithelial cells with
Soulette CM; Hrabeta-Robinson E; Arevalo C; Felton C; Tang AD; Marin MG; Brooks AN
Life Sci Alliance; 2023 Oct; 6(10):. PubMed ID: 37487637
[No Abstract] [Full Text] [Related]
26. Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor
Yuan X; Sabzvar MK; Patil AD; Chinnaswamy K; Howie KL; Andhavaram R; Wang B; Siegler MA; Dumaz A; Stuckey JA; Corey SJ; Maciejewski JP; Visconte V; Yang CY
Res Sq; 2024 Jun; ():. PubMed ID: 38883705
[TBL] [Abstract][Full Text] [Related]
27. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
28. Spliceosome mutations in hematopoietic malignancies.
Hahn CN; Scott HS
Nat Genet; 2011 Dec; 44(1):9-10. PubMed ID: 22200771
[TBL] [Abstract][Full Text] [Related]
29. U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
Qian J; Yao DM; Lin J; Qian W; Wang CZ; Chai HY; Yang J; Li Y; Deng ZQ; Ma JC; Chen XX
PLoS One; 2012; 7(9):e45760. PubMed ID: 23029227
[TBL] [Abstract][Full Text] [Related]
30. Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal.
Xu JJ; Smeets MF; Tan SY; Wall M; Purton LE; Walkley CR
Exp Hematol; 2019 Feb; 70():10-23. PubMed ID: 30408513
[TBL] [Abstract][Full Text] [Related]
31. Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasms.
Wedge E; Ahmadov U; Hansen TB; Gao Z; Tulstrup M; Côme C; Nonavinkere Srivatsan S; Ahmed T; Jespersen JS; Schlotmann BC; Schöllkopf C; Raaschou-Jensen K; Ødum N; Kjems J; Bak RO; Walter MJ; Grønbæk K; Kristensen LS
Leukemia; 2023 May; 37(5):1113-1125. PubMed ID: 36922625
[TBL] [Abstract][Full Text] [Related]
32. Mutant U2AF1-induced differential alternative splicing causes an oxidative stress in bone marrow stromal cells.
Liu Z; Dong X; Cao Z; Qiu S; Li Y; Zhong M; Xue Z; Xu Y; Xing H; Tang K; Tian Z; Wang M; Rao Q; Wang J
Exp Biol Med (Maywood); 2021 Aug; 246(15):1750-1759. PubMed ID: 34034558
[TBL] [Abstract][Full Text] [Related]
33. U2AF1 mutations alter splice site recognition in hematological malignancies.
Ilagan JO; Ramakrishnan A; Hayes B; Murphy ME; Zebari AS; Bradley P; Bradley RK
Genome Res; 2015 Jan; 25(1):14-26. PubMed ID: 25267526
[TBL] [Abstract][Full Text] [Related]
34. U2AF1 expression is a novel and independent prognostic indicator of childhood T-lineage acute lymphoblastic leukemia.
Zhang P; Zhang Y; Li X; Ying P; Tang Y
Int J Lab Hematol; 2021 Aug; 43(4):675-682. PubMed ID: 33314767
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.
Hong JY; Seo JY; Kim SH; Jung HA; Park S; Kim K; Jung CW; Kim JS; Park JS; Kim HJ; Jang JH
Anticancer Res; 2015 May; 35(5):3081-9. PubMed ID: 25964599
[TBL] [Abstract][Full Text] [Related]
36. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review).
Nian Q; Li Y; Li J; Zhao L; Rodrigues Lima F; Zeng J; Liu R; Ye Z
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975232
[TBL] [Abstract][Full Text] [Related]
37. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
[TBL] [Abstract][Full Text] [Related]
38. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.
Graubert TA; Shen D; Ding L; Okeyo-Owuor T; Lunn CL; Shao J; Krysiak K; Harris CC; Koboldt DC; Larson DE; McLellan MD; Dooling DJ; Abbott RM; Fulton RS; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Grillot M; Baty J; Heath S; Frater JL; Nasim T; Link DC; Tomasson MH; Westervelt P; DiPersio JF; Mardis ER; Ley TJ; Wilson RK; Walter MJ
Nat Genet; 2011 Dec; 44(1):53-7. PubMed ID: 22158538
[TBL] [Abstract][Full Text] [Related]
39. Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
Hamilton BK; Visconte V; Jia X; Tabarroki A; Makishima H; Hasrouni E; Abounader D; Kalaycio M; Sekeres MA; Sobecks R; Duong Liu H; Bolwell B; Maciejewski JP; Copelan E; Tiu RV
Am J Hematol; 2016 Jun; 91(4):406-9. PubMed ID: 26799334
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.
Wu SJ; Tang JL; Lin CT; Kuo YY; Li LY; Tseng MH; Huang CF; Lai YJ; Lee FY; Liu MC; Liu CW; Hou HA; Chen CY; Chou WC; Yao M; Huang SY; Ko BS; Tsay W; Tien HF
Am J Hematol; 2013 Nov; 88(11):E277-82. PubMed ID: 23861105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]